정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 317 | Recruiting | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) | COVID-19 | Drug: Remdesivir | Phase 3 | Gilead Sciences | INDUSTRY | 52 | All | ~ 18 Years | Children's Hospital of Alabama, Birmingham, Alabama, United States Children's Hospital Los Angeles, Los Angeles, California, United States Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, California, United States Valley Children's Hospital, Madera, California, United States Rady Children's Hospital San Diego, San Diego, California, United States Tampa General Hospital (Inpatient Visits), Tampa, Florida, United States Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States Norton Children's Hospital, Louisville, Kentucky, United States Tulane University School of Medicine, New Orleans, Louisiana, United States Johns Hopkins Children's Center, Baltimore, Maryland, United States Boston Children's Hospital, Boston, Massachusetts, United States UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States Children's Hospital of Michigan, Detroit, Michigan, United States Spectrum Health/Helen De Vos Children's Hospital, Grand Rapids, Michigan, United States Children's Minnesota, Minneapolis, Minnesota, United States Children's Hospital & Medical Center, Omaha, Nebraska, United States NYC Health + Hospitals/Jacobi Medical Center, Bronx, New York, United States Montefiore Medical Center, Bronx, New York, United States Northwell Health-Cohen Children's Medical Center, New Hyde Park, New York, United States Carolinas Medical Center-Levine Children's Hospital, Charlotte, North Carolina, United States Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN), Allentown, Pennsylvania, United States St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States Children's Medical Center, Dallas, Texas, United States Texas Children's Hospital, Houston, Texas, United States Azienda Ospedaliero Universitaria Meyer, Florence, Italy University Hospital of Padova, Clinic of Pediatric Hematology-Oncology, Padova, Italy University Hospital of Parma, Parma, Italy Hospital Universitari Vall D'Hebron, Barcelona, Spain Hospital Sant Joan de Deu, Esplugues de llobregat, Spain Hospital General Universitario Gregorio Maranon, Madrid, Spain Hospital Universitario 12 de Octubre, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom King's College NHS Foundation Trust, London, United Kingdom |
| 316 | Withdrawn | Study to Investigate the Benefits of Colchicine in Patients With COVID-19 | Covid-19 | Drug: Colchicine | Phase 3 | Liaquat University of Medical & Health Sciences, Universidad de Murcia | OTHER | 0 | All | 18 Years | |
| 315 | Completed | Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home | COVID-19 | Drug: standard of care for COVID-19 as per the hospital guidelines Dietary Supplement: Quercetin Phytosome (QP) |
Not Applicable | King Edward Medical University | OTHER | 100 | All | 18 Years | King Edward Medical University Teaching Hospital, Lahore, Punjab, Pakistan |
| 314 | Not yet recruiting | Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19 | Covid19 | Drug: Hospital standard of care for COVID-19 Drug: Isoquercetin |
Phase 2 | Nepal Health Research Council | OTHER_GOV | 250 | All | 18 Years | |
| 313 | Recruiting | Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants | Healthy | Drug: PF-07304814 | Phase 1 | Pfizer | INDUSTRY | 5 | All | 18 Years ~ 55 Years | Labcorp Clinical Research Unit, Madison, Wisconsin, United States |
| 312 | Recruiting | Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Mild-to-moderate COVID-19 | Covid19 | Drug: Standard of care Dietary Supplement: BLIS K12 |
Not Applicable | King Edward Medical University | OTHER | 50 | All | 18 Years | King Edward Medical University Teaching Hospital, Lahore, Punjab, Pakistan |
| 311 | Completed | Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 | COVID-19 | Drug: Colchicine Drug: Standard COVID-19 care |
Phase 3 | Ayub Teaching Hospital, Universidad de Murcia | OTHER | 102 | All | 18 Years ~ 65 Years | Ayub Teaching Hospital, Abbottabad, Khyber Pakhtunkhwa, Pakistan |